Cargando…
Future perspectives for advancing regulatory science of nanotechnology-enabled health products
The identification of regulatory challenges for nanotechnology-enabled health products, followed by discussions with the involved stakeholders, is the first step towards a strategic planning of how such challenges can be successfully addressed in the future. In order to better understand whether the...
Autores principales: | Halamoda-Kenzaoui, Blanka, Geertsma, Robert, Pouw, Joost, Prina-Mello, Adriele, Carrer, Moreno, Roesslein, Matthias, Sips, Adrienne, Weltring, Klaus Michael, Spring, Kathleen, Bremer-Hoffmann, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360093/ https://www.ncbi.nlm.nih.gov/pubmed/35691982 http://dx.doi.org/10.1007/s13346-022-01165-y |
Ejemplares similares
-
Main trends of immune effects triggered by nanomedicines in preclinical studies
por: Halamoda-Kenzaoui, Blanka, et al.
Publicado: (2018) -
Mapping of the available standards against the regulatory needs for nanomedicines
por: Halamoda‐Kenzaoui, Blanka, et al.
Publicado: (2018) -
REFINE special issue
por: Spring, Kathleen, et al.
Publicado: (2022) -
Toxic effects of nanomaterials for health applications: How automation can support a systematic review of the literature?
por: Halamoda‐Kenzaoui, Blanka, et al.
Publicado: (2021) -
Differential stress reaction of human colon cells to oleic-acid-stabilized and unstabilized ultrasmall iron oxide nanoparticles
por: Schütz, Catherine A, et al.
Publicado: (2014)